In particular, IL-6 is a pleiotropic mediator with a pivotal role in RA pathogenesis [21], exerting potent immunomodulatory effects on the balance between Th17 cells and CD4posCD25posFoxP3pos regulatory T lymphocytes in RA patients [11]. This evidence concerns the gene IL6 and rheumatoid arthritis.